GLP-1 Drugs Linked to Scurvy Risk Amid Rising Popularity
GLP-1 drugs, commonly used for weight loss, have been linked to an increased risk of scurvy, a disease caused by severe vitamin C deficiency. This condition, historically associated with sailors, has emerged as a concern for users of these medications. English singer Robbie Williams reported being diagnosed with scurvy after using a drug similar to Ozempic, highlighting the potential nutritional deficiencies associated with these medications. GLP-1 agonists, including Ozempic, Wegovy, and Mounjaro, are known for their appetite-suppressing effects, which can lead to rapid weight loss. However, this can also result in inadequate nutrient intake, as noted by dietitians. Clare Collins, a leading dietitian, emphasized the importance of maintaining a balanced diet while using these drugs, as many global trials have not adequately considered patients' nutritional needs. 
